Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2372 posts found.

PureTech Health launches Seaport Therapeutics

April 9, 2024 Business Services Financing, Neurology, PureTech Health, launch

PureTech Health has announced key progress on its ‘strategic initiatives to deliver innovative medicines to patients and unlock value for …

Johnson & Johnson to acquire Shockwave Medical

April 8, 2024 Business Services Cardiology, Johnson & Johnson, Shockwave Medical, acquisition

Johnson & Johnson (J&J) and Shockwave Medical have announced that they have entered into a definitive agreement under which J&J …

FDA approves Roche’s test for malaria in blood donors

April 2, 2024 Business Services FDA, Infections and infestations, blood donation, malaria

Roche has announced that the US Food and Drug Administration (FDA) has approved its cobas Malaria test for use on …

PMLiVE’s T40 – open for submissions!

March 28, 2024 Business Services PMLive, PMLive T40, Pharmacy, T40

Healthcare agencies can submit their entries free of charge with a deadline of 30 April The 2024 edition of PMLiVE’s …

Abenza announces investment in bioconjugation and ADC capabilities

March 28, 2024 Business Services ADC, Abenza, Pharmacy, bioconjugation, investment

Abenza has announced a major investment in bioconjugation and antibody drug conjugate (ADC) capabilities in response to an increasing industry …

Provectus Biopharmaceuticals announces license agreement with University of Miami

March 28, 2024 Business Services License Agreement, Opthalmology, Provectus Biopharmaceuticals, University of Miami

Provectus Biopharmaceuticals has announced that it has entered into an exclusive worldwide license agreement with the University of Miami, US …

AbbVie to acquire Landos Biopharma for approximately $137.5m

March 26, 2024 Business Services AbbVie, Landos Biopharma, Pharmacy, acquisition

AbbVie and Landos Biopharma have announced that they have entered into a definitive agreement under which AbbVie will acquire Landos …

AstraZeneca to acquire Fusion for approximately $2bn

March 19, 2024 Business Services AstraZeneca, Fusion Pharmaceuticals, Oncology, acquisition, radioconjugates

AstraZeneca has announced that it has entered into a definitive agreement to acquire Fusion Pharmaceuticals for an approximate $2bn. This …

AstraZeneca to acquire Amolyt Pharma for up to $1.05bn

March 14, 2024 Business Services Amolyt Pharma, AstraZeneca, Rare Diseases, acquisition, rare diseases

AstraZeneca has announced that it has entered into a definitive agreement under which it will acquire Amolyt Pharma for up …

Merck completes acquisition of Harpoon Therapeutics for $650m

March 12, 2024 Business Services Harpoon Therapeutics, Merck, Oncology, lung cancer

Merck, known as MSD outside of the US and Canada, has announced that it has completed the acquisition of Harpoon …

Johnson & Johnson acquires Ambrx Biopharma for approximately $2bn

March 11, 2024 Business Services ADCs, Ambrx Biopharma, J&J, Johnson & Johnson, Oncology, acquisition

Johnson & Johnson (J&J) has announced that it has successfully completed its acquisition of Ambrx Biopharma in an all-cash merger …

Aspire Pharma acquires Cenoté Pharma

March 11, 2024 Business Services Aspire Pharma, Cenoté Pharma, Pharmacy, acquisition

Aspire Pharma has announced that it has successfully acquired Cenoté Pharma as part of its plan to supplement its growth …

Domainex opens new Biology Centre of Excellence in Cambridge, UK

February 14, 2024 Business Services Pharmacy, domainex, facility

Domainex has announced that it has opened a new Biology Centre of Excellence at the Unity Campus at Pampisford, Cambridge, …
brano-mm1vipqd0oa-unsplash

Jazz Pharmaceuticals enters agreement to acquire rights to KRAS inhibitor programme from Redx Pharma

February 7, 2024 Business Services Pharmacy, RedX Pharma, acquisition, jazz pharmaceuticals

Jazz Pharmaceuticals and Redx Pharma have announced that the companies have signed a definitive agreement under which Jazz will acquire …

Novartis to acquire MorphoSys AG for €2.7bn

February 6, 2024 Business Services Novartis, Pharmacy, acquisition, morphosys

Novartis has announced that it has entered an agreement to acquire MorphoSys AG for €2.7bn, or €68 per share. The …

Latest content